Tetrahydropalmatine Alleviates Osteoarthritis‐Associated Pain and Inflammation by Suppressing KDM4A / MDM2 / HIF ‐1α‐Mediated M1 Macrophage Polarization
Chemical Biology & Drug Design · 2026-03 · 107 (3)
DOI: 10.1111/cbdd.70279 ↗At a glance
Journal article in Chemical Biology & Drug Design, published online on 2026-03-19. Written by Xiaobo Chen and 5 co-authors. Institution: Department of Rehabilitation, The Second Affiliated Hospital of Gannan Medical University, Ganzhou, China. Major MEDLINE topics: Osteoarthritis, Berberine Alkaloids, Jumonji Domain-Containing Histone Demethylases, Inflammation. Cited 1 times so far (Crossref); 40 references.
Abstract (original language)
Osteoarthritis (OA)‐associated pain, driven by M1 macrophage polarization and inflammation, lacks effective therapies. Tetrahydropalmatine (THP), known for its anti‐inflammatory and analgesic properties, was evaluated for its effects on OA‐induced pain and macrophage polarization. A destabilization of the medial meniscus (DMM)‐induced OA mouse model and lipopolysaccharide (LPS)‐stimulated RAW264.7 macrophages were used. Behavioral tests, histology, immunofluorescence, enzyme‐linked immunosorbent assay (ELISA), reverse transcription‐quantitative polymerase chain reaction (RT‐qPCR), Western blotting (WB), and immunohistochemistry (IHC) were used to assess pain, inflammation, and the expression of lysine demethylase 4A (KDM4A), murine double minute 2 (MDM2), and hypoxia‐inducible factor‐1α (HIF‐1α). THP treatment alleviated OA‐induced pain and cartilage damage and reduced CD86 expression, and reduced the expression of pro‐inflammatory factors tumor necrosis factor‐α (TNF‐α), inducible nitric oxide synthase (iNOS), interleukin‐6 (IL‐6), and key signaling molecules (KDM4A, MDM2, and HIF‐1α). Mechanistically, KDM4A directly bound to the MDM2 promoter and activated its transcription via H3K9me3 demethylation, whereas MDM2 enhanced HIF‐1α signaling to promote M1 polarization. Overexpression of KDM4A reversed the inhibitory effects of THP on MDM2/HIF‐1α signaling and inflammation. These findings indicate that THP mitigates OA‐associated pain and inflammation by blocking KDM4A‐mediated MDM2 transcription and suppressing HIF‐1α‐dependent M1 macrophage polarization, highlighting the KDM4A‐MDM2‐HIF‐1α axis as a potential therapeutic target.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Rehabilitation, The Second Affiliated Hospital of Gannan Medical University, Ganzhou, China.
- Department of Traditional Chinese Medicine, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
- Department of Pharmacy, The Second Affiliated Hospital of Gannan Medical University, Ganzhou, China.
- Department of Rehabilitation, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
ORCID profiles: Ying Yang
Cite
APA
Chen, X., Sun, X., Zhong, Q., Gan, H., Lv, W., & Yang, Y. (2026). Tetrahydropalmatine Alleviates Osteoarthritis‐Associated Pain and Inflammation by Suppressing KDM4A / MDM2 / HIF ‐1α‐Mediated M1 Macrophage Polarization. Chemical Biology & Drug Design, 107(3). https://doi.org/10.1111/cbdd.70279
Vancouver
Chen X, Sun X, Zhong Q, Gan H, Lv W, Yang Y. Tetrahydropalmatine Alleviates Osteoarthritis‐Associated Pain and Inflammation by Suppressing KDM4A / MDM2 / HIF ‐1α‐Mediated M1 Macrophage Polarization. Chemical Biology & Drug Design. 2026;107(3). doi:10.1111/cbdd.70279
BibTeX
@article{Chen2026,
author = {Chen, Xiaobo and Sun, Xiaoyong and Zhong, Qiuming and Gan, Hongxia and Lv, Weiping and Yang, Ying},
title = {Tetrahydropalmatine Alleviates Osteoarthritis‐Associated Pain and Inflammation by Suppressing KDM4A / MDM2 / HIF ‐1α‐Mediated M1 Macrophage Polarization},
journal = {Chemical Biology & Drug Design},
year = {2026},
volume = {107},
number = {3},
doi = {10.1111/cbdd.70279}
}
EUVIMED